The present invention provides methods for identifying a patient at risk
for developing AMD by identifying the presence of the Y402H polymorphism
or other at risk variants in the complement factor H gene. The present
invention further provides methods for treating persons having AMD or at
risk for developing AMD as a result of having the Y402H polymorphism or
other at risk variants in the complement factor H gene.